Tweets
Drug Survival Differences in RA, PsA, SpA and PsO
https://t.co/aBRhTbVmCM https://t.co/ZDGiKlowoV
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Rheumatoid Arthritis and Eosinophilia
Considerations when eosinophilia is seen in RA patients.
QD Clinic is sponsored by https://t.co/4UQlqwujiR (March 19 & 20, 2022 in Las Colinas, Texas)
https://t.co/2FszCiTLgf https://t.co/07uZT2heW3
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
New Download Available!
Autoimmune Disease in the USA
https://t.co/KvsgBUY7mL https://t.co/PSTF7ma6G6
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
2021 Top Articles from Arthritis & Rheumatology
https://t.co/nxKWrkdGX3 https://t.co/iZx5MOUyA7
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
CORVITAS RA registry shows poor biologic responses in Severe obesity (BMI >35) & underweight (<18.5) w/ no diff between 2891 TNFi vs 3010 non-TNFi users. Severe obesity lower odds of LDA, MCID, CDAI ~10-20% UnderWt ~50-70% https://t.co/iMvlyo4UKx https://t.co/JTQ6aRVTpH
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
ICYMI: Spondyloarthritis in Early Crohn's Disease
Analysis of a German Crohn's disease cohort finds that in patients with early CD, SpA was present in nearly one out of five patients and was associated with HLA-B27 positivity and a highly active CD.
https://t.co/ExAHSCw5v2 https://t.co/UDZHbg9ySY
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
ICYMI: Increased SLE Flares with HCQ Reduction
Concerns about the long-term safety of HCQ often results in dose reduction or drug discontinuation; study shows that, for those in remission, HCQ taper/discontinuation resulted in a higher rate of SLE flares.
https://t.co/l0Xh1oQzQA https://t.co/HyDbqKrEFp
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
ICYMI: NEJM case - Whats the diagnosis? 31yoM w/ 10yr hx of clubbing, arthralgias, nailfold hyperpigmentation, Tender DIPs, toes; xrays showed bony proliferation. Labs and PET were normal. Rx w/ NSAIDs and improved w/ specific Rx? https://t.co/gJ922ToXe9 https://t.co/vyuxLA5SkL
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
ICYMI: INBUILD Study of 170 pts with autoimmune related ILD showed nintedanib signifi. slowed the rate of FVC decline in FVC decline over 52 wks (NIN -75.9 mL/yr vs PBO -178.6 mL/yr). AE's (mostly diarrhea) leading to D/C was NIN 17.1% vs PBO 10.2% https://t.co/1h2recxnqn https://t.co/d930Xij3Zv
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
ICYMI: FDA approved 2/28/22
IV (intravenous) Actemra for GCA: dose 6mg/kg q4 weeks (don't exceed 600 mg/dose)
https://t.co/QhIq6dHGSf
TheDaoIndex @KDAO2011 ( View Tweet )
4 years 4 months ago
ICYMI: Psoriatic fingernail onycholysis and hyperkeratosis, rather than nail pitting, are significantly & independently assoc w/ PsA. Study of 1985 pts w/psoriasis, 11.5% were Dx w/ PsA. Only onycholysis (OR 2.34) and hyperkeratosis ) were assoc w/ PsA https://t.co/5K8L5WKQXs https://t.co/InDPhLrIUK
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago
Download this week’s podcast titled “When Less (Drug) is More (Activity) “
https://t.co/FESVNenri9 https://t.co/PVGGjkgcTV
Links:
Dr. John Cush @RheumNow ( View Tweet )
4 years 4 months ago


